CryoPort, Inc. has developed an innovative, proprietary transport and packaging system focused on providing a solution that replaces dry ice for the frozen shipping market in the growing global life science industry. Its products have a 10+ day holding time and use “green” materials. The company’s goal is to become an essential component of the global logistical infrastructure required for the testing, research and end-user delivery of temperature-sensitive medicines and biomaterials.
The company today announced that it has named Karen M. Muller to its Board of Directors. Ms. Muller is a corporate attorney with more than 25 years of experience as both a company executive and legal counsel. She will serve as an independent director, giving CryoPort three independent directors.
Ms. Muller currently has a private practice with clients in the healthcare, pharmaceutical and medical device industries. She recently served as a director and consultant to Naturade, a leading nutrition and nutraceutical company.
Previously, she was chief administrative officer and general counsel of Epoch Networks. While at Epoch, Ms. Muller helped complete the restructuring and sale of Epoch’s internet service provider (ISP) business, the largest privately-held ISP in the country.
Prior to joining Epoch, she was a managing director with Lehman Brothers, heading the corporate counsel department. Earlier, Ms. Muller was an associate at the Wall Street law firm Cahill, Gordon & Reindel, where she worked on corporate finance and mergers and acquisitions.
For further information about CryoPort, please visit the company’s website at www.cryoport.com